GSNPX
Price
$25.21
Change
+$0.10 (+0.40%)
Updated
Jun 2 closing price
Net Assets
3.55B
TRTIX
Price
$26.28
Change
+$0.15 (+0.57%)
Updated
Jun 2 closing price
Net Assets
17.12B
Interact to see
Advertisement

GSNPX vs TRTIX

Header iconGSNPX vs TRTIX Comparison
Open Charts GSNPX vs TRTIXBanner chart's image
GSNPX vs TRTIX Comparison Chart in %
View a ticker or compare two or three
VS
GSNPX vs. TRTIX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSNPX is a StrongBuy and TRTIX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
TRTIX has more cash in the bank: 17.1B vs. GSNPX (3.55B). TRTIX pays higher dividends than GSNPX: TRTIX (2.52) vs GSNPX (2.32). GSNPX was incepted earlier than TRTIX: GSNPX (8 years) vs TRTIX (11 years). GSNPX (0.83) is less costly to investors than TRTIX (0.68). GSNPX is a more actively managed with annual turnover of: 49.00 vs. TRTIX (15.00). GSNPX has a lower initial minimum investment than TRTIX: GSNPX (0) vs TRTIX (500000). TRTIX annual gain was more profitable for investors over the last year : 29.56 vs. GSNPX (24.09). TRTIX return over 5 years is better than : 84.98 vs. GSNPX (78.17).
GSNPXTRTIXGSNPX / TRTIX
Total Expense Ratio0.800.68118%
Annual Report Gross Expense Ratio0.830.68122%
Fund Existence8 years11 years-
Gain YTD10.27711.05093%
Front LoadN/AN/A-
Min. Initial Investment0500000-
Min. Initial Investment IRAN/AN/A-
Net Assets3.55B17.1B21%
Annual Yield % from dividends2.322.5292%
Returns for 1 year24.0929.5681%
Returns for 3 years70.3189.1379%
Returns for 5 years78.1784.9892%
Returns for 10 yearsN/A151.13-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
API5.260.51
+10.74%
Agora
ECCC24.52-0.02
-0.06%
Eagle Point Credit Company
AR36.26-0.50
-1.36%
ANTERO RESOURCES Corp
HOUR1.93-0.04
-1.83%
Hour Loop
ELVN35.52-1.99
-5.31%
Enliven Therapeutics